EP3334462B8
(en )
2022-04-20
Covalent linkers in antibody-drug conjugates and methods of making and using the same
EP3137114B8
(en )
2021-08-04
Anti-ptk7 antibody-drug conjugates
SMT202400223T1
(en )
2024-07-09
Conjugates comprising self-immolative groups and methods related thereto
IL248961A0
(en )
2017-01-31
Auristatin derivatives and conjugates thereof
EP3157560A4
(en )
2018-02-21
Her2 antibody-drug conjugates
PL3102606T3
(en )
2019-05-31
Antibody-drug conjugates and immunotoxins
EP3049443A4
(en )
2017-04-05
Anti-trop-2 antibody-drug conjugates and uses thereof
PL3102244T3
(en )
2020-11-02
Antibody-drug conjugates and immunotoxins
IL275208A
(en )
2020-07-30
Hsp90-targeting conjugates and formulations thereof
IL272625A
(en )
2020-03-31
Pyrrolobenzodiazepine conjugates
EP3129047A4
(en )
2017-05-10
Stable formulations for anti-cd19 antibodies and antibody-drug conjugates
IL269945B
(en )
2021-05-31
Pyrrolobenzodiazepine conjugates
EP3538098A4
(en )
2020-07-29
Antibody-drug conjugates
EP3142650A4
(en )
2018-01-10
Curcumin-peptide conjugates and formulations thereof
HK1261954A1
(en )
2020-01-10
Antibody-drug conjugates comprising branched linkers and methods related thereto
HK40092426A
(en )
2023-12-22
Anti-edb antibodies and antibody-drug conjugates
HK40032578A
(en )
2021-03-26
Methods of assessing antibody-drug conjugates
HK40038485A
(en )
2021-06-25
Hsp90-targeting conjugates and formulations thereof
HK40036554A
(en )
2021-05-28
Sstr-targeted conjugates and formulations thereof
HK40016060A
(en )
2020-09-04
Hsp90-targeting conjugates and formulations thereof
GB201721337D0
(en )
2018-01-31
Pyrrolobenzodiazepine conjugates
HK40015017A
(en )
2020-08-28
Peptide-containing linkers for antibody-drug conjugates
HK1261001A1
(en )
2019-12-27
Eribulin-based antibody-drug conjugates and methods of use
HK1236442A1
(en )
2018-03-29
Her2 antibody-drug conjugates
GB201706133D0
(en )
2017-05-31
Pyrrolobenzodiazepine conjugates